Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9JK1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,113
Award facts
- Contract value 100% obligated
- $38,113.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,113.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 4,570 units of Dupixent 300 mg/2 mL pens on January 2, 2026, with an ultimate completion date of January 5, 2026. This order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic medication commonly used to treat moderate-to-severe atopic dermatitis, asthma, and other allergic conditions, reflecting the Defense Logistics Agency's ongoing medical supply needs for military healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen leverages this comprehensive global pharmaceutical support vehicle to supply a wide range of medications and medical supplies across multiple therapeutic domains to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded contracts demonstrates its established capability to meet federal procurement requirements across varying order sizes and product categories.
Quick answers
Who was awarded contract SPE2DR26F9JK1?
SPE2DR26F9JK1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 2, 2026.
How much is contract SPE2DR26F9JK1 worth?
The government has obligated $38,113 on SPE2DR26F9JK1.
Is contract SPE2DR26F9JK1 an order under another contract?
Yes. SPE2DR26F9JK1 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9JK1 competed?
The extent of competition for SPE2DR26F9JK1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award